APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanopore Long-Reads Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nanopore Long-Reads Sequencing Market Outlook and Growth Opportunities 2026

4 July 2026197 pages

Choose your research edition.

Industry ResearchNanopore Long-Reads Sequencing Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanopore Long-Reads Sequencing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nanopore Long-Reads Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanopore Long-Reads Sequencing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanopore Long-Reads Sequencing Market Analysis and Forecast 2026-2032176 pages · $4,950 USD

Market perspective

The global Nanopore Long-Reads Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nanopore Long-Reads Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nanopore Long-Reads Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanopore Long-Reads Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nanopore Long-Reads Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nanopore Long-Reads Sequencing market include Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Limited, Thermo Fisher, Roche, 10X Genomics, Eurofins Genomics, Stratos Genomics, Inc., MicrobesNG and NextOmics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nanopore Long-Reads Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nanopore Long-Reads Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nanopore Long-Reads Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nanopore Long-Reads Sequencing market.

Nanopore Long-Reads Sequencing Segment by Company

Pacific Biosciences of California, Inc.

Oxford Nanopore Technologies Limited

Thermo Fisher

Roche

10X Genomics

Eurofins Genomics

Stratos Genomics, Inc.

MicrobesNG

NextOmics

New England Biolabs

Pacbio

Illumina

Stratos Genomics

Nanopore Long-Reads Sequencing Segment by Type

Pre-sequencing

Sequencing

Data Analysis

Nanopore Long-Reads Sequencing Segment by Application

Medical

Non-medical

Nanopore Long-Reads Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nanopore Long-Reads Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nanopore Long-Reads Sequencing key companies, revenue, market share, and recent developments.

3. To split the Nanopore Long-Reads Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nanopore Long-Reads Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nanopore Long-Reads Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Nanopore Long-Reads Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Long-Reads Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanopore Long-Reads Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Long-Reads Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanopore Long-Reads Sequencing industry.

Chapter 3: Detailed analysis of Nanopore Long-Reads Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nanopore Long-Reads Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nanopore Long-Reads Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nanopore Long-Reads Sequencing Industry Trends Table 2. Nanopore Long-Reads Sequencing Industry Drivers Table 3. Nanopore Long-Reads Sequencing Industry Opportunities and Challenges Table 4. Nanopore Long-Reads Sequencing Industry Restraints Table 5. Global Nanopore Long-Reads Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nanopore Long-Reads Sequencing Revenue Share by Company (2021-2026) Table 7. Global Nanopore Long-Reads Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nanopore Long-Reads Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Nanopore Long-Reads Sequencing Company, Product Type & Application Table 10. Global Nanopore Long-Reads Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nanopore Long-Reads Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pre-sequencing Table 15. Significant Companies of Sequencing Table 16. Significant Companies of Data Analysis Table 17. Global Nanopore Long-Reads Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Nanopore Long-Reads Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Nanopore Long-Reads Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Nanopore Long-Reads Sequencing Sales Value Share by Type (2021-2026) Table 21. Global Nanopore Long-Reads Sequencing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical Table 23. Significant Companies of Non-medical Table 24. Global Nanopore Long-Reads Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nanopore Long-Reads Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Nanopore Long-Reads Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Nanopore Long-Reads Sequencing Sales Value Share by Application (2021-2026) Table 28. Global Nanopore Long-Reads Sequencing Sales Value Share by Application (2027-2032) Table 29. Global Nanopore Long-Reads Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nanopore Long-Reads Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Nanopore Long-Reads Sequencing Sales Value Share by Region (2021-2026) Table 32. Global Nanopore Long-Reads Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Nanopore Long-Reads Sequencing Sales Value Share by Region (2027-2032) Table 34. Global Nanopore Long-Reads Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nanopore Long-Reads Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Nanopore Long-Reads Sequencing Sales Value Market Share by Country (2021-2026) Table 37. Global Nanopore Long-Reads Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Nanopore Long-Reads Sequencing Sales Value Market Share by Country (2027-2032) Table 39. Pacific Biosciences of California, Inc. Company Information Table 40. Pacific Biosciences of California, Inc. Business Overview Table 41. Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Product Portfolio Table 43. Pacific Biosciences of California, Inc. Recent Development Table 44. Oxford Nanopore Technologies Limited Company Information Table 45. Oxford Nanopore Technologies Limited Business Overview Table 46. Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Product Portfolio Table 48. Oxford Nanopore Technologies Limited Recent Development Table 49. Thermo Fisher Company Information Table 50. Thermo Fisher Business Overview Table 51. Thermo Fisher Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Nanopore Long-Reads Sequencing Product Portfolio Table 53. Thermo Fisher Recent Development Table 54. Roche Company Information Table 55. Roche Business Overview Table 56. Roche Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Roche Nanopore Long-Reads Sequencing Product Portfolio Table 58. Roche Recent Development Table 59. 10X Genomics Company Information Table 60. 10X Genomics Business Overview Table 61. 10X Genomics Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. 10X Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 63. 10X Genomics Recent Development Table 64. Eurofins Genomics Company Information Table 65. Eurofins Genomics Business Overview Table 66. Eurofins Genomics Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Eurofins Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 68. Eurofins Genomics Recent Development Table 69. Stratos Genomics, Inc. Company Information Table 70. Stratos Genomics, Inc. Business Overview Table 71. Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Product Portfolio Table 73. Stratos Genomics, Inc. Recent Development Table 74. MicrobesNG Company Information Table 75. MicrobesNG Business Overview Table 76. MicrobesNG Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. MicrobesNG Nanopore Long-Reads Sequencing Product Portfolio Table 78. MicrobesNG Recent Development Table 79. NextOmics Company Information Table 80. NextOmics Business Overview Table 81. NextOmics Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. NextOmics Nanopore Long-Reads Sequencing Product Portfolio Table 83. NextOmics Recent Development Table 84. New England Biolabs Company Information Table 85. New England Biolabs Business Overview Table 86. New England Biolabs Nanopore Long-Reads Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. New England Biolabs Nanopore Long-Reads Sequencing Product Portfolio Table 88. New England Biolabs Recent Development Table 89. Pacbio Company Information Table 90. Pacbio Business Overview Table 91. Pacbio Nanopore Long-Reads Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Pacbio Nanopore Long-Reads Sequencing Product Portfolio Table 93. Pacbio Recent Development Table 94. Illumina Company Information Table 95. Illumina Business Overview Table 96. Illumina Nanopore Long-Reads Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Illumina Nanopore Long-Reads Sequencing Product Portfolio Table 98. Illumina Recent Development Table 99. Stratos Genomics Company Information Table 100. Stratos Genomics Business Overview Table 101. Stratos Genomics Nanopore Long-Reads Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Stratos Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 103. Stratos Genomics Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Nanopore Long-Reads Sequencing Product Image Figure 2. Global Nanopore Long-Reads Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanopore Long-Reads Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Nanopore Long-Reads Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pre-sequencing Image Figure 8. Sequencing Image Figure 9. Data Analysis Image Figure 10. Global Nanopore Long-Reads Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Nanopore Long-Reads Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Nanopore Long-Reads Sequencing Sales Value Share by Type (2021-2032) Figure 13. Medical Image Figure 14. Non-medical Image Figure 15. Global Nanopore Long-Reads Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nanopore Long-Reads Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nanopore Long-Reads Sequencing Sales Value Share by Application (2021-2032) Figure 18. Global Nanopore Long-Reads Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Nanopore Long-Reads Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Nanopore Long-Reads Sequencing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Nanopore Long-Reads Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Nanopore Long-Reads Sequencing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Nanopore Long-Reads Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Nanopore Long-Reads Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Nanopore Long-Reads Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Nanopore Long-Reads Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Nanopore Long-Reads Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Nanopore Long-Reads Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Nanopore Long-Reads Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-sequencing
  • Sequencing
  • Data Analysis
Applications
  • Medical
  • Non-medical
Companies covered
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Limited
  • Thermo Fisher
  • Roche
  • 10X Genomics
  • Eurofins Genomics
  • Stratos Genomics, Inc.
  • MicrobesNG
  • NextOmics
  • New England Biolabs
  • Pacbio
  • Illumina
  • Stratos Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nanopore Long-Reads Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nanopore Long-Reads Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nanopore Long-Reads Sequencing Market Dynamics
  1. 2.1 Nanopore Long-Reads Sequencing Industry Trends
  2. 2.2 Nanopore Long-Reads Sequencing Industry Drivers
  3. 2.3 Nanopore Long-Reads Sequencing Industry Opportunities and Challenges
  4. 2.4 Nanopore Long-Reads Sequencing Industry Restraints
3 Nanopore Long-Reads Sequencing Market by Company
  1. 3.1 Global Nanopore Long-Reads Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Nanopore Long-Reads Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Nanopore Long-Reads Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Nanopore Long-Reads Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Nanopore Long-Reads Sequencing Company Product Type and Application
  6. 3.6 Global Nanopore Long-Reads Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nanopore Long-Reads Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nanopore Long-Reads Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nanopore Long-Reads Sequencing Market by Type
  1. 4.1 Nanopore Long-Reads Sequencing Type Introduction
  2. 4.1.1 Pre-sequencing
  3. 4.1.2 Sequencing
  4. 4.1.3 Data Analysis
  5. 4.2 Global Nanopore Long-Reads Sequencing Sales Value by Type
  6. 4.2.1 Global Nanopore Long-Reads Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nanopore Long-Reads Sequencing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Nanopore Long-Reads Sequencing Sales Value Share by Type (2021-2032)
5 Nanopore Long-Reads Sequencing Market by Application
  1. 5.1 Nanopore Long-Reads Sequencing Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Non-medical
  4. 5.2 Global Nanopore Long-Reads Sequencing Sales Value by Application
  5. 5.2.1 Global Nanopore Long-Reads Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nanopore Long-Reads Sequencing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Nanopore Long-Reads Sequencing Sales Value Share by Application (2021-2032)
6 Nanopore Long-Reads Sequencing Regional Value Analysis
  1. 6.1 Global Nanopore Long-Reads Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nanopore Long-Reads Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nanopore Long-Reads Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nanopore Long-Reads Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nanopore Long-Reads Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Nanopore Long-Reads Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nanopore Long-Reads Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Nanopore Long-Reads Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nanopore Long-Reads Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nanopore Long-Reads Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nanopore Long-Reads Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Nanopore Long-Reads Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nanopore Long-Reads Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nanopore Long-Reads Sequencing Sales Value Share by Country, 2025 VS 2032
7 Nanopore Long-Reads Sequencing Country-level Value Analysis
  1. 7.1 Global Nanopore Long-Reads Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nanopore Long-Reads Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nanopore Long-Reads Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nanopore Long-Reads Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nanopore Long-Reads Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nanopore Long-Reads Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nanopore Long-Reads Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pacific Biosciences of California, Inc.
  2. 8.1.1 Pacific Biosciences of California, Inc. Company Information
  3. 8.1.2 Pacific Biosciences of California, Inc. Business Overview
  4. 8.1.3 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Product Portfolio
  6. 8.1.5 Pacific Biosciences of California, Inc. Recent Developments
  7. 8.2 Oxford Nanopore Technologies Limited
  8. 8.2.1 Oxford Nanopore Technologies Limited Company Information
  9. 8.2.2 Oxford Nanopore Technologies Limited Business Overview
  10. 8.2.3 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Product Portfolio
  12. 8.2.5 Oxford Nanopore Technologies Limited Recent Developments
  13. 8.3 Thermo Fisher
  14. 8.3.1 Thermo Fisher Company Information
  15. 8.3.2 Thermo Fisher Business Overview
  16. 8.3.3 Thermo Fisher Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Nanopore Long-Reads Sequencing Product Portfolio
  18. 8.3.5 Thermo Fisher Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Nanopore Long-Reads Sequencing Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 10X Genomics
  26. 8.5.1 10X Genomics Company Information
  27. 8.5.2 10X Genomics Business Overview
  28. 8.5.3 10X Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 10X Genomics Nanopore Long-Reads Sequencing Product Portfolio
  30. 8.5.5 10X Genomics Recent Developments
  31. 8.6 Eurofins Genomics
  32. 8.6.1 Eurofins Genomics Company Information
  33. 8.6.2 Eurofins Genomics Business Overview
  34. 8.6.3 Eurofins Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurofins Genomics Nanopore Long-Reads Sequencing Product Portfolio
  36. 8.6.5 Eurofins Genomics Recent Developments
  37. 8.7 Stratos Genomics, Inc.
  38. 8.7.1 Stratos Genomics, Inc. Company Information
  39. 8.7.2 Stratos Genomics, Inc. Business Overview
  40. 8.7.3 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Product Portfolio
  42. 8.7.5 Stratos Genomics, Inc. Recent Developments
  43. 8.8 MicrobesNG
  44. 8.8.1 MicrobesNG Company Information
  45. 8.8.2 MicrobesNG Business Overview
  46. 8.8.3 MicrobesNG Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MicrobesNG Nanopore Long-Reads Sequencing Product Portfolio
  48. 8.8.5 MicrobesNG Recent Developments
  49. 8.9 NextOmics
  50. 8.9.1 NextOmics Company Information
  51. 8.9.2 NextOmics Business Overview
  52. 8.9.3 NextOmics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 NextOmics Nanopore Long-Reads Sequencing Product Portfolio
  54. 8.9.5 NextOmics Recent Developments
  55. 8.10 New England Biolabs
  56. 8.10.1 New England Biolabs Company Information
  57. 8.10.2 New England Biolabs Business Overview
  58. 8.10.3 New England Biolabs Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs Nanopore Long-Reads Sequencing Product Portfolio
  60. 8.10.5 New England Biolabs Recent Developments
  61. 8.11 Pacbio
  62. 8.11.1 Pacbio Company Information
  63. 8.11.2 Pacbio Business Overview
  64. 8.11.3 Pacbio Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pacbio Nanopore Long-Reads Sequencing Product Portfolio
  66. 8.11.5 Pacbio Recent Developments
  67. 8.12 Illumina
  68. 8.12.1 Illumina Company Information
  69. 8.12.2 Illumina Business Overview
  70. 8.12.3 Illumina Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Illumina Nanopore Long-Reads Sequencing Product Portfolio
  72. 8.12.5 Illumina Recent Developments
  73. 8.13 Stratos Genomics
  74. 8.13.1 Stratos Genomics Company Information
  75. 8.13.2 Stratos Genomics Business Overview
  76. 8.13.3 Stratos Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Stratos Genomics Nanopore Long-Reads Sequencing Product Portfolio
  78. 8.13.5 Stratos Genomics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst